Fact CheckerSign in

NCT05486455Recruiting

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers: a "Real Life" Study

Source: ClinicalTrials.gov · Last updated 6 Dec 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1000 (estimated)
First submitted
1 Aug 2022
Start date
4 Nov 2022
Primary completion date
31 Oct 2028
Lead sponsor
Hospital St. Joseph, Marseille, France
Diseases
Lung cancer
NCT number
NCT05486455

What you commit to

  • Study type: Interventional
  • Planned participants: 1000
  • From 4 Nov 2022 to the primary completion date, 31 Oct 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Recent history of chest CT scan (within 12 months)

Age

  • Personal history of cancer \< 5 years (currently being monitored by thoracic imaging)

Other

  • Person unable to climb 2 floors
  • Weight \> 140kg

Who the study is looking for

  • Male or female 50-80 years old
  • Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Saint Joseph
Coordinator of this site? Confirm its status
MarseilleFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.